DNA gyrase is one of the most fascinating enzymes in microbiology and biotechnology. Unlike other enzymes that work on very specific reactions, DNA gyrase has a broad and essential role in keeping DNA properly shaped and functional. This enzyme belongs to the type II topoisomerase family, which means it works by cutting both strands of DNA and then rejoining them.
For researchers, DNA gyrase is more than just a biological curiosity. It has become a critical target in antibiotic development and an essential tool in biotechnology. Because bacteria depend on DNA gyrase for survival, many modern antibiotics are designed to block its function. At the same time, in biotechnology and agriculture, this enzyme is being studied for applications that range from drug discovery to genetic engineering.
This article explores DNA gyrase in detail: its structure, function, applications, role in antibiotic resistance, and the broader landscape of research and innovation connected to it.
The structure of DNA gyrase is central to its function. It is a heterotetrameric enzyme composed of two types of subunits:
Together, two GyrA and two GyrB subunits form an A2B2 complex. This complex is highly conserved among bacteria, which means its basic design is almost identical across many bacterial species.
1. The enzyme binds to a segment of DNA.
2. It creates a double-stranded break in one region.
3. Another segment of DNA is passed through this break.
4. The enzyme re-ligates the broken DNA strands.
5. Using ATP, it introduces negative supercoils, reducing tension in the DNA.
This action is not just about relaxing DNA—it actively changes the topology of the DNA molecule, which is crucial during replication forks when the DNA must be unwound for new strands to form.
Because of its essential role, DNA gyrase is considered one of the most important enzymes in prokaryotic cells, and blocking it is often lethal to bacteria.
DNA gyrase is vital to bacterial life because it manages the supercoiling of DNA. In every cell cycle, DNA must be replicated, transcribed, and repaired. Each of these steps involves unwinding the DNA helix, which naturally causes tension in the molecule. If not corrected, this tension can stop replication and even break DNA strands.
In prokaryotes, DNA gyrase is the only enzyme capable of introducing negative supercoils. This makes it indispensable for their survival.
In eukaryotic cells, similar functions are carried out by other topoisomerases, but none perform the exact negative supercoiling activity of DNA gyrase. This is one of the main reasons why DNA gyrase is an excellent antibiotic target: inhibiting it harms bacteria but not human cells.
In summary, the biological role of DNA gyrase can be grouped into three main areas:
One of the most important aspects of DNA gyrase is its role in antibiotic action. Many of the world's most widely used antibiotics work by blocking DNA gyrase activity, stopping bacterial growth and killing infections.
Both classes have been incredibly successful in treating bacterial infections.
Unfortunately, bacteria can develop mutations in the genes encoding GyrA and GyrB. These mutations reduce antibiotic binding, making the drugs less effective. In addition, some bacteria produce efflux pumps that push antibiotics out of the cell, further limiting their effect.
This resistance is now a major global health issue. DNA gyrase mutations are one of the main reasons why fluoroquinolone resistance is rising worldwide.
Beyond medicine, DNA gyrase has a wide range of uses in research and industry.
DNA gyrase assays are used to screen new antibacterial compounds, making it one of the most studied enzymes in pharma pipelines.
Because of these uses, DNA gyrase is often included in biochemical assay kits and experimental systems provided by biotechnology suppliers, making it a high-demand target in research markets.
DNA gyrase is also gaining attention in biotechnology and agricultural industries.
Some crop pathogens rely heavily on DNA gyrase. By designing inhibitors specific to these pathogens, it may be possible to protect crops without harming beneficial organisms.
Although much of this work is still experimental, the agricultural biotech field recognizes DNA gyrase as a promising target for sustainable farming solutions.
Q1: Is DNA gyrase found in humans?
No. DNA gyrase is only found in bacteria. Humans and other eukaryotes have topoisomerases, but none with the same function.
Q2: What antibiotics target DNA gyrase?
Fluoroquinolones (like ciprofloxacin) and coumarins (like novobiocin) are the main classes.
Q3: How do bacteria become resistant to gyrase-targeting drugs?
Mutations in gyrase subunits or efflux pumps that expel antibiotics lead to resistance.
Q4: Can DNA gyrase be used in biotechnology?
Yes, it is widely used in drug screening, DNA manipulation, and synthetic biology applications.
DNA gyrase is the engine that keeps bacterial DNA functional, the target of some of our most important antibiotics, and an exciting tool in biotechnology and agriculture.
As antibiotic resistance continues to rise, understanding and targeting DNA gyrase will remain a central focus in drug discovery. At the same time, new industrial and agricultural applications highlight its growing importance beyond medicine.
Amerigo Scientific is proud to support researchers by providing high-quality products, reagents, and custom services that enable breakthroughs in fields like molecular biology, drug discovery, and biotechnology. By offering reliable tools for studying enzymes such as DNA gyrase, Amerigo Scientific helps scientists advance solutions for medicine, agriculture, and beyond.
Note: If you don't receive our verification email, do the following: